PRMT1 and Miyoshi myopathy: Furthermore, we found MM patients with higher R-ISS stage in TCGA cohort (p = 0.009, p = 0.02, Supplementary Fig. 1C) and GSE136324 (p = 0.0023, p = 0.0014, Fig. 1B) and ISS stage in GSE136324 (p = 0.0022, p = 0.0368, Fig. 1C) exhibited higher levels of PRMT1 expression.